Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists.
An expression system that utilized yeast copper metallothionein promoter and ubiquitin fusion technology to express the human estrogen receptor gene in yeast is described. We have studied the biochemical and transcriptional regulatory properties of the human estrogen receptor. The biochemical properties of the yeast expressed receptors are identical to the receptors isolated from human tissue. Estradiol mediated activation of transcription by the receptor was studied by a reporter beta-galactosidase gene where expression was under the control of estrogen response elements. Using this expression system and a hyperpermeable yeast strain we have studied the effects of various antiestrogens on the regulation of estrogen receptor function. We demonstrate that tamoxifen and ICI 164,384 are capable of binding to the receptor but neither antiestrogen was able to block the estradiol mediated increase in transcription. In fact, both antiestrogens exerted weak agonist activity in this system.
Lyttle
C R
CR
Department of Obstetrics and Gynecology, University of Pennsylvania, School of Medicine 19104-6140.
Damian-Matsumura
P
P
Juul
H
H
Butt
T R
TR
D000595:Amino Acid Sequence; D015153:Blotting, Western; D003001:Cloning, Molecular; D004965:Estrogen Antagonists / Q000494:pharmacology; D006801:Humans; D008954:Models, Biological; D008969:Molecular Sequence Data; D011960:Receptors, Estrogen / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000235:genetics*; D013629:Tamoxifen / Q000494:pharmacology; D014452:Ubiquitins / Q000235:genetics / Q000378:metabolism
D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D011993:Recombinant Fusion Proteins; D014452:Ubiquitins; D013629:Tamoxifen